Header Artwork
Header Artwork



Method Development for Decontamination and Sterile Processing of Personal Protective Equipment (PPE)

Published Date: June 26, 2020

Throughout the COVID-19 crisis there has been a huge emphasis on bringing critical products to the healthcare market in a timely fashion.  This webinar will feature our collective learnings on required novel approaches to decontamination/sterile processing of items such as PPE. Manufacturers, regulators and end users have been pressed to develop new processing methods in a very accelerated fashion. It is important to understand when developing new methods that while accelerated or abbreviated test methods may be required, that does not obviate the need for holistic view ensuring all critical parameters are tested.

Participants Will Learn:

  • New process development on an accelerated timeline
  • Review of literature- understanding the study purpose and test conditions
  • Regulatory landscape around accelerated process and testing development
  • Value of multidisciplinary experience
  • Example of test method development- Disinfection protocols

Alpa Patel

Senior Scientist, RM (NCRM)

Alpa Patel is a certified microbiologist and has been part of the medical device industry for 18 years specializing in cleaning/disinfection and sterilization of reusable medical devices, endoscopes and validation of tissue disinfection or sterilization processes. Her current role as a principal scientist at Nelson, involves overseeing test method validations for reprocessing, writing standard test protocols (STP) and standard operating procedures (SOP) for reprocessing and other internal and globally related documents, providing technical consulting for the Reprocessing sections at Nelson Laboratories in Salt Lake City and globally.


Aaron Dement

Vice President of Technical Services

Aaron DeMent has been with Sterigenics for over 20 years and currently serves as Vice President of Technical Services. In this capacity he oversees the Expert Advisory Services group who are responsible for validation protocol development and execution for the EO, E-Beam, Gamma and Nitrogen Dioxide Processes. In addition, the Technical Services group is responsible for exploring new sterilization technologies as well as the company EO Reduction Initiatives. Prior to his current position, he served as the Global Vice President Quality Assurance for Sterigenics. In this capacity he oversaw compliance to regulatory and quality standards for all of the Sterigenics sites globally. Aaron has held a variety of positions including Director, QA, GM, QA Manager, R&D Principal Sterilization Scientist, Sterilization Manager, Corporate Training Manager and QA/ Sterilization Consultant.

Complete the following information to access the webinar